180 related articles for article (PubMed ID: 29632060)
1. Medical Care Costs Associated With Cancer in Integrated Delivery Systems.
Banegas MP; Yabroff KR; O'Keeffe-Rosetti MC; Ritzwoller DP; Fishman PA; Salloum RG; Lafata JE; Hornbrook MC
J Natl Compr Canc Netw; 2018 Apr; 16(4):402-410. PubMed ID: 29632060
[No Abstract] [Full Text] [Related]
2. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
3. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
4. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
5. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
6. System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum.
Kaye DR; Min HS; Norton EC; Ye Z; Li J; Dupree JM; Ellimoottil C; Miller DC; Herrel LA
J Oncol Pract; 2018 Mar; 14(3):e149-e157. PubMed ID: 29443647
[TBL] [Abstract][Full Text] [Related]
7. Projections of the cost of cancer care in the United States: 2010-2020.
Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
[TBL] [Abstract][Full Text] [Related]
8. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
[TBL] [Abstract][Full Text] [Related]
9. Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma.
Hollenbeak CS; Nikkel LE; Schaefer EW; Alemao E; Ghahramani N; Raman JD
J Manag Care Pharm; 2011 Oct; 17(8):610-20. PubMed ID: 21942302
[TBL] [Abstract][Full Text] [Related]
10. Estimating health care costs related to cancer treatment from SEER-Medicare data.
Brown ML; Riley GF; Schussler N; Etzioni R
Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
[TBL] [Abstract][Full Text] [Related]
11. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
Riley GF; Potosky AL; Lubitz JD; Kessler LG
Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
[TBL] [Abstract][Full Text] [Related]
12. Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.
Deshmukh AA; Zhao H; Franzini L; Lairson DR; Chiao EY; Das P; Swartz MD; Giordano SH; Cantor SB
Am J Clin Oncol; 2018 Feb; 41(2):121-127. PubMed ID: 26523440
[TBL] [Abstract][Full Text] [Related]
13. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
[TBL] [Abstract][Full Text] [Related]
14. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
Etzioni R; Ramsey SD; Berry K; Brown M
Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
[TBL] [Abstract][Full Text] [Related]
15. Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors.
Shen C; Dasari A; Gu D; Chu Y; Zhou S; Xu Y; Halperin D; Fu S; Yao JC; Shih YT
Pharmacoeconomics; 2018 Aug; 36(8):1005-1013. PubMed ID: 29682693
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Attributable Medical Costs for Colorectal Cancer Patients by Phases of Care: What Is the Effect of a Prior Cancer History?
Mariotto AB; Warren JL; Zeruto C; Coughlan D; Barrett MJ; Zhao L; Yabroff KR
J Natl Cancer Inst Monogr; 2020 May; 2020(55):22-30. PubMed ID: 32412066
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
[TBL] [Abstract][Full Text] [Related]
19. Phase-specific and lifetime costs of cancer care in Ontario, Canada.
de Oliveira C; Pataky R; Bremner KE; Rangrej J; Chan KK; Cheung WY; Hoch JS; Peacock S; Krahn MD
BMC Cancer; 2016 Oct; 16(1):809. PubMed ID: 27756310
[TBL] [Abstract][Full Text] [Related]
20. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care.
Taplin SH; Barlow W; Urban N; Mandelson MT; Timlin DJ; Ichikawa L; Nefcy P
J Natl Cancer Inst; 1995 Mar; 87(6):417-26. PubMed ID: 7861461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
